A detailed history of Ubs Group Ag transactions in Illumina, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 26,000 shares of ILMN stock, worth $3.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,000
Previous 324,655 91.99%
Holding current value
$3.72 Million
Previous $33.9 Million 90.0%
% of portfolio
0.0%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $428,068 - $552,569
4,066 Added 1.25%
328,721 $42.9 Million
Q2 2024

Aug 13, 2024

BUY
$101.05 - $133.57 $1.02 Million - $1.35 Million
10,136 Added 3.22%
324,655 $33.9 Million
Q1 2024

May 13, 2024

BUY
$127.73 - $147.2 $690,380 - $795,615
5,405 Added 1.75%
314,519 $43.2 Million
Q4 2023

Feb 09, 2024

BUY
$92.79 - $142.53 $12.4 Million - $19 Million
133,157 Added 75.68%
309,114 $43 Million
Q3 2023

Nov 09, 2023

SELL
$128.91 - $192.44 $7.46 Million - $11.1 Million
-57,876 Reduced 24.75%
175,957 $24.2 Million
Q2 2023

Aug 11, 2023

BUY
$183.43 - $232.67 $13.1 Million - $16.6 Million
71,205 Added 43.78%
233,833 $43.8 Million
Q1 2023

May 12, 2023

SELL
$193.75 - $232.55 $10.3 Million - $12.4 Million
-53,226 Reduced 24.66%
162,628 $37.8 Million
Q4 2022

Feb 08, 2023

BUY
$187.24 - $242.74 $14.7 Million - $19.1 Million
78,559 Added 57.22%
215,854 $43.6 Million
Q3 2022

Nov 10, 2022

SELL
$177.23 - $227.44 $9.61 Million - $12.3 Million
-54,221 Reduced 28.31%
137,295 $26.2 Million
Q2 2022

Aug 10, 2022

SELL
$181.58 - $368.0 $6.45 Million - $13.1 Million
-35,549 Reduced 15.66%
191,516 $35.3 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $42.7 Million - $59.5 Million
-140,380 Reduced 38.2%
227,065 $79.3 Million
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $13.1 Million - $15.9 Million
-37,789 Reduced 9.33%
367,445 $140 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $19.5 Million - $25.2 Million
48,008 Added 13.44%
405,234 $164 Million
Q2 2021

Aug 13, 2021

BUY
$372.84 - $481.5 $58.2 Million - $75.2 Million
156,109 Added 77.62%
357,226 $169 Million
Q1 2021

May 12, 2021

SELL
$361.28 - $504.76 $32 Million - $44.7 Million
-88,545 Reduced 30.57%
201,117 $77.2 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $325,775 - $412,878
1,113 Added 0.39%
289,662 $107 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $4.66 Million - $6.96 Million
17,360 Added 6.4%
288,549 $89.2 Million
Q2 2020

Jul 31, 2020

SELL
$256.46 - $373.01 $2.55 Million - $3.71 Million
-9,948 Reduced 3.54%
271,189 $100 Million
Q1 2020

May 01, 2020

SELL
$209.2 - $335.53 $9.96 Million - $16 Million
-47,599 Reduced 14.48%
281,137 $76.8 Million
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $22.9 Million - $26.7 Million
79,489 Added 31.89%
328,736 $109 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $7.08 Million - $10 Million
26,533 Added 11.91%
249,247 $75.8 Million
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $10.7 Million - $13 Million
-35,445 Reduced 13.73%
222,714 $82 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $14.8 Million - $17.5 Million
54,438 Added 26.72%
258,159 $80.2 Million
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $18.1 Million - $24.3 Million
-66,345 Reduced 24.57%
203,721 $61.1 Million
Q3 2018

Nov 14, 2018

BUY
$279.04 - $367.06 $24.5 Million - $32.2 Million
87,677 Added 48.07%
270,066 $99.1 Million
Q2 2018

Aug 14, 2018

SELL
$228.17 - $292.07 $1.99 Million - $2.55 Million
-8,722 Reduced 4.56%
182,389 $50.9 Million
Q1 2018

May 15, 2018

SELL
$209.54 - $253.91 $915,270 - $1.11 Million
-4,368 Reduced 2.23%
191,111 $45.2 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $9.05 Million - $10.3 Million
44,774 Added 29.71%
195,479 $42.7 Million
Q3 2017

Nov 14, 2017

SELL
$172.3 - $213.93 $1.44 Million - $1.79 Million
-8,352 Reduced 5.25%
150,705 $30 Million
Q2 2017

Aug 14, 2017

BUY
N/A
39,375 Added 32.9%
159,057 $27.6 Million
Q1 2017

Nov 14, 2017

BUY
N/A
119,682
119,682 $20.4 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.